Stanley L Mullen, 48Kissimmee, FL

Known as:

Stanley L Muller

Related to:

Deborah R Mangis 73 Erich A Muller 84

Stanley Mullen Phones & Addresses

Kissimmee, FL   

16 Branch Pl, Lincoln Park, NJ 07035    973-6321178   

8 Mandon Dr, Wayne, NJ 07470    973-6965245   

Seaside Heights, NJ   

Social networks

Stanley L Mullen

Linkedin

Get Report

---

Control this profile

Share profile:

Mentions for Stanley L Mullen

Career records & work history

Medicine Doctors

Stanley P. Mullen

Specialties:

Diagnostic Radiology

Work:

Murfreesboro Radiology Inc
1700 Medical Ctr Pkwy, Murfreesboro, TN 37129
615-3964100 (phone) 615-3965706 (fax)

Education:

Medical School
University of Tennessee College of Medicine at Memphis
Graduated: 1982

Languages:

English

Description:

Dr. Mullen graduated from the University of Tennessee College of Medicine at Memphis in 1982. He works in Murfreesboro, TN and specializes in Diagnostic Radiology. Dr. Mullen is affiliated with Cumberland River Hospital and Saint Thomas Rutherford Hospital.

Stanley Mullen resumes & CV records

Resumes

Stanley Mullen

Location:

United States

Publications & IP owners

Wikipedia

Stanley Mullen

Stanley Mullen (June 20, 1911 (1911-06-20) 1973) was an American artist, short story writer, novelist and publisher. He studied writing at the University of Colorado at Boulder and ...

Us Patents

Novel Hcv Inhibitor Combinations And Methods

US Patent:

2007022, Sep 27, 2007

Filed:

Feb 9, 2007

Appl. No.:

11/704505

Inventors:

Emillo Emini - Dresher PA, US
Michael Flint - Wayne PA, US
Anita Howe - Paoli PA, US
Bruce Malcolm - Paoli PA, US
Stanley Mullen - Lincoln Park NJ, US
Robert Ralston - Union NJ, US
Xiao Tong - East Brunswick NJ, US

Assignee:

Schering Corporation - Kenilworth NJ
ViroPharma Incorporated - Exton PA
Wyeth - Madison NJ

International Classification:

A61K 38/21
A61K 31/7056
A61K 31/407
A61K 31/343

US Classification:

424085400, 514412000, 514043000, 514469000

Abstract:

Novel hepatitis C virus (“HCV”) inhibitor combinations comprising an HCV protease inhibitor and HCV polymerase inhibitor, and optionally one or more biologically active agents, as well as uses of these combinations as HCV inhibitors and for treating hepatitis C and related disorders are disclosed.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.